COMP <GO>
KMTS vs UFPT // REVENUE GROWTH (YOY)
Kestra Medical Technologies Ltd. (NASDAQ) VS. UFP Technologies Inc. (NASDAQ) • 15-METRIC TALLY: KMTS 4
— UFPT 6
▲ REVENUE GROWTH (YOY) LEADER: KMTS
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
revenue-growth
59.00%
LAST: $293.30 (+2.55%) • MKT CAP: $2.27B
revenue-growth
19.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KMTS VS. UFPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KMTS | UFPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.40% | 28.30% | +23.10 | KMTS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 13.90% | -48.90 | UFPT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 25.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.40% | 4.05% | -10.45 | UFPT | /fcf-yield <GO> |
| Operating Margin | -60.00% | 15.30% | -75.30 | UFPT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 11.30% | -71.30 | UFPT | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 59.00% | 19.50% | +39.50 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.65 | 8.31 | +1.34 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 44.0 | +13.50 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $2.27B | -$448.7M | UFPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KMTS REV | UFPT REV | KMTS GROSS % | UFPT GROSS % | KMTS FCF | UFPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $95.1M | $602.8M | 51.4% | 28.3% | -$116.6M | $91.9M |
| FY 2024 | $59.8M | $504.4M | 40.5% | 29.1% | -$100.5M | $56.9M |
| FY 2023 | $27.8M | $400.1M | — | — | -$72.2M | $41.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KMTS // BETA —
UFPT // BETA —